U.S. Household Products Stock News

NasdaqGM:XNCR
NasdaqGM:XNCRBiotechs

Do Xencor’s (XNCR) Mixed 2026 Loss Trends Hint at Shifting Cost Discipline?

Xencor, Inc. reported past second-quarter 2026 results showing a reduced net loss of US$21.73 million, or US$0.29 per share, while its net loss for the first half of 2026 widened to US$150.65 million, or US$1.99 per share. This contrast between an improving quarterly loss and a much larger year-to-date loss highlights the company’s uneven cost profile and execution so far in 2026. We’ll now examine how the narrower quarterly loss but much larger year-to-date loss could influence Xencor’s...
NasdaqGS:GLNG
NasdaqGS:GLNGOil and Gas

Did Golar LNG’s New US$2.45 Billion FLNG Order Just Shift GLNG’s Investment Narrative?

In the past week, Golar LNG reported Q2 2026 results showing quarterly revenue of US$130.48 million and net income of US$38.27 million, and confirmed an Engineering, Procurement and Construction deal for a fourth FLNG vessel with a total project budget of about US$2.45 billion. The new MKII FLNG order, which lifts Golar’s controlled liquefaction capacity by about 40% to above 12 million tons per annum, materially extends its long-term growth runway in the floating LNG market. We’ll now...
NYSE:BRX
NYSE:BRXRetail REITs

What Is Drawing Attention To Brixmor Property Group (BRX)?

Insider sale and new leases put Brixmor in focus A recent insider sale has put Brixmor Property Group (BRX) on investors’ radar again. Director Michael B. Berman sold 9,000 shares on August 12, while the company highlighted record new leasing commitments. See our latest analysis for Brixmor Property Group. At around US$29.98, Brixmor Property Group’s 1 month share price return is down 7.95%, even though its year to date share price return is up 15.49% and the 5 year total shareholder return...
NYSE:REZI
NYSE:REZIBuilding

What Is Drawing Fresh Attention To Resideo Technologies (REZI)?

Resideo Technologies (REZI) is back in focus after a reset in analyst expectations tied to fresh guidance, the ADI Global Distribution spin off, leadership changes, and a swing to quarterly profitability. See our latest analysis for Resideo Technologies. At a share price of US$20.50, Resideo Technologies has seen the 30 day share price return fall 42.79%, even though the three year total shareholder return sits at 83.52%. This suggests that recent momentum has cooled after a stronger multi...
NYSE:SARO
NYSE:SAROAerospace & Defense

The Bull Case For StandardAero (SARO) Could Change Following Strong Q2, Raised Outlook And LEAP Profitability

In the past quarter, StandardAero, Inc. reported Q2 2026 sales of US$1,599.69 million and net income of US$97.28 million, alongside higher earnings per share and an increased full-year 2026 revenue outlook to US$6,375 million–US$6,500 million. Beyond the headline results, StandardAero reached profitability on its LEAP and CFM56 programs and committed to a US$180 million license expansion expected to lift recurring adjusted EBITDA. We will now examine how the new full-year guidance and LEAP...
NYSE:DVA
NYSE:DVAHealthcare

Stronger Q2 Earnings and Transplant Focus Might Change The Case For Investing In DaVita (DVA)

DaVita Inc. has reported past second-quarter 2026 results showing revenue of US$3,554.08 million and net income of US$265.4 million, with both basic and diluted earnings per share from continuing operations increasing compared with the prior year period. Beyond the financials, DaVita highlighted its role in strengthening the kidney transplant ecosystem through paired kidney exchange programs and support for non-directed living donors, underscoring its broader involvement in patient care...
NYSE:PFE
NYSE:PFEPharmaceuticals

Pfizer Stock And 2 AI Healthcare Picks Built Around Productivity Growth

With global bond yields high and borrowing costs less forgiving, capital is flowing toward companies that can raise productivity rather than just cut expenses. Transformative AI healthcare stocks sit right in that sweet spot. They use data and algorithms to help doctors work faster and more accurately, which can appeal when every dollar needs to work harder. This article highlights three AI healthcare stocks from our screener to watch closely. The three stocks below are just a sample from...
NasdaqGS:VIAV
NasdaqGS:VIAVCommunications

Viavi Solutions (VIAV) Could Be 29% Undervalued As Vertex 6.0 Debuts

Viavi Solutions (VIAV) has released Vertex 6.0, presented as the industry's first channel emulator designed for next generation 6G and Wi Fi 7/8 testing, shortly after acquiring Spirent's channel emulation business. See our latest analysis for Viavi Solutions. The Vertex 6.0 launch sits alongside strong price momentum for Viavi Solutions, with a 7 day share price return of 11.24% and a 1 month share price return of 14.10%, although the 3 month share price return is down 12.48%. Over a longer...
NasdaqGM:XENE
NasdaqGM:XENEBiotechs

Xenon Pharmaceuticals (XENE) Could Be 23% Undervalued As Epilepsy Growth Narrative Holds

Xenon Pharmaceuticals (NasdaqGM:XENE) is back in focus after reporting a second quarter net loss of US$110.74 million and preparing to present at Stifel’s 2026 Biotech Summer Summit on August 10 in Newport. See our latest analysis for Xenon Pharmaceuticals. Despite the wider loss, Xenon Pharmaceuticals shares have cooled in the last month with a 1-month share price return of down 8.66% and a 7-day move of down 1.59%. However, the 90-day share price return of 16.09% and 1-year total...
NYSE:CWK
NYSE:CWKReal Estate

Why Cushman & Wakefield (CWK) Is Back In The Spotlight

Cushman & Wakefield (CWK) is back in focus after its latest quarterly update, which met Wall Street earnings expectations while revenue came in ahead of forecasts, highlighting broad-based expansion in its global real estate services platform. See our latest analysis for Cushman & Wakefield. At a share price of $14.40, Cushman & Wakefield has seen momentum build in recent weeks, with 30 day and 90 day share price returns of 5.42% and 13.92%. However, the year to date share price return is...
NYSE:BW
NYSE:BWElectrical

Is Babcock & Wilcox Enterprises (BW) Undervalued As Siemens Data Center Deals Lift Guidance?

Babcock & Wilcox Enterprises (BW) is back in focus after agreeing with Siemens Energy to start work on 20 steam turbine generator sets for data center projects, alongside higher financial guidance and a sizeable project pipeline. See our latest analysis for Babcock & Wilcox Enterprises. Those Siemens Energy turbines and the stronger guidance seem to be feeding into the price action. Babcock & Wilcox Enterprises now trades at US$10.29, with a 1 day share price return of 10.05% and a year to...
NYSE:KIM
NYSE:KIMRetail REITs

What Is Drawing Attention To Kimco Realty (KIM) Today?

Kimco Realty (KIM) drew fresh attention after raising its full year 2026 net income guidance and lifting its quarterly dividend by 12%. These updates highlighted management’s current outlook and cash returns to shareholders. See our latest analysis for Kimco Realty. At a share price of $24.41, Kimco Realty has combined a 21.68% year to date share price return with a 20.49% total shareholder return over the past year. This points to momentum that has remained broadly supportive through recent...
NYSEAM:UMAC
NYSEAM:UMACElectronic

3 High Growth Stocks In AI Infrastructure And Digital Banking To Watch

Several regions report stronger than expected domestic demand, even as inflation and energy costs stay in focus. That mix often pushes investors to look more closely at companies where analysts see earnings growth potential and balance sheets that appear solid. This article picks out three stocks from the Healthy high growth potential screener and explains why each one could merit a place on your watchlist right now. The three stocks highlighted below are just a starting sample from this...
NasdaqGM:QMCO
NasdaqGM:QMCOTech

Quantum (QMCO) Is Up 116.9% After Stronger Revenue, Record Backlog And Upbeat Q2 Guidance - What's Changed

In the first quarter ended June 30, 2026, Quantum Corporation reported revenue of US$80.8 million, up from US$64.29 million a year earlier, alongside a net loss of US$155.29 million and a basic loss per share from continuing operations of US$7.06. Despite the wider loss, Quantum issued fiscal second-quarter 2027 revenue guidance of about US$82.0 million and pointed to a record backlog, a cleaner balance sheet, and easing supply constraints that analysts say are reshaping expectations for...
NasdaqGS:INVA
NasdaqGS:INVAPharmaceuticals

Innoviva’s Earnings Swing And Buyback Might Change The Case For Investing In Innoviva (INVA)

Innoviva, Inc. has reported past second-quarter 2026 results showing revenue of US$119.59 million, up from US$100.28 million a year earlier, but shifting from a net income of US$63.69 million to a net loss of US$83.42 million, while also completing a share repurchase of 3,055,966 shares for US$66.40 million under its existing program. Despite the quarterly loss, Innoviva’s six-month figures to June 30, 2026 show revenue rising to US$217.59 million and net income increasing to US$103.18...
NYSE:CNS
NYSE:CNSCapital Markets

How Cohen & Steers’ New Real Assets Active ETF Could Reshape the CNS Investment Story

In August 2026, Cohen & Steers, Inc. launched the Cohen & Steers Real Assets Active ETF (CSRA) on NYSE Arca, offering actively managed, diversified exposure across listed real estate, infrastructure, natural resources and commodities. This launch consolidates several real-asset exposures into a single ETF, potentially simplifying portfolio construction for investors already using Cohen & Steers’ broader active ETF lineup. We’ll now examine how the CSRA real assets launch could influence...
NYSE:HCC
NYSE:HCCMetals and Mining

Warrior Met Coal (HCC) Is Up 6.8% After Boosting Profitability And Raising Full‑Year Sales Guidance

In August 2026, Warrior Met Coal, Inc. reported that second-quarter revenue rose to US$509.69 million and net income to US$87.43 million, with basic earnings per share from continuing operations increasing to US$1.65 compared with US$0.11 a year earlier. The company also grew production volumes, returned to profitability for the first half of the year, and raised its full‑year coal sales guidance after stronger‑than‑expected customer adoption of Blue Creek volumes. Now, we’ll examine how...
NasdaqGS:OTTR
NasdaqGS:OTTRElectric Utilities

Quarterly Loss, Lower EPS Outlook And Dividend Payout Might Change The Case For Investing In Otter Tail (OTTR)

In early August 2026, Otter Tail Corporation reported second-quarter results showing revenue of US$334.38 million but a net loss of US$7.61 million, cut its 2026 diluted earnings per share guidance to a range of US$3.84 to US$4.24, and declared a quarterly dividend of US$0.5775 per share payable in September. The combination of a quarterly loss tied to settlement-related expenses, a lower full-year earnings outlook, and an ongoing cash dividend highlights the tension between Otter Tail’s...
NYSE:CNC
NYSE:CNCHealthcare

Does Centene’s Debt Redemption Plan Reshape Its Medicaid and Medicare Growth Narrative for CNC?

In recent months, Centene has outlined higher expectations for future revenue and earnings and announced a plan to redeem part of its debt, aiming to strengthen its balance sheet and profitability profile. This shift comes as the company remains priced on the lower side of its price-to-sales multiples versus peers, despite concerns about underwhelming customer growth and pressured returns on capital. Now, we’ll explore how Centene’s debt redemption plan reshapes its existing investment...
NasdaqGS:ATLC
NasdaqGS:ATLCConsumer Finance

Atlanticus Holdings (ATLC) Shares Just Moved, So What Is Driving Attention Now?

Atlanticus Holdings (ATLC) is back in focus after reporting record profits for Q2 2026, supported by revenue and customer growth tied to the Mercury acquisition and continued positive credit performance. See our latest analysis for Atlanticus Holdings. The recent record Q2 profits and ongoing integration of Mercury have coincided with strong momentum in Atlanticus Holdings, with a 90 day share price return of 30.59% and a 1 year total shareholder return of 67.20%. If this kind of strong move...
NYSE:BKSY
NYSE:BKSYProfessional Services

BlackSky Technology (BKSY) Is Up 6.0% After Winning Multi-Year International Geospatial Intelligence Contract

Earlier this month, BlackSky Technology Inc. announced it had secured an international seven-figure, multi-year contract combining Assured and On-Demand subscriptions for integrated Gen-2 and Gen-3 satellite imagery and AI-enabled analytics, following a successful pilot. The deal underscores growing customer integration of BlackSky’s Spectra platform into real-world operations, signaling deeper, workflow-embedded demand for its low-latency geospatial intelligence services. Next, we’ll...
NYSE:FTK
NYSE:FTKChemicals

Is Flotek’s Upgraded Outlook And Puerto Rico Deal Altering The Investment Case For Flotek Industries (FTK)?

Flotek Industries, Inc. recently reported past second-quarter 2026 results showing higher revenue and net income year over year, raised its 2026 total revenue guidance to US$340 million–US$350 million, and secured a 10-year Puerto Rico power project agreement expected to create about US$400 million in revenue backlog. Together, the upgraded outlook and long-term Puerto Rico contract highlight a shift toward more recurring, infrastructure-linked revenues that could reshape how investors...
NYSE:GEV
NYSE:GEVElectrical

Cameco Stock And 2 Nuclear Power Picks For Higher Electricity Demand

Rising long term US and European bond yields are keeping borrowing costs elevated, which puts real pressure on energy projects that burn fuel and face volatile input prices. Reliable, carbon free baseload power that is not tied to commodity swings suddenly looks more attractive. That is where the Nuclear Renaissance screener comes in. This article walks through three stocks from the screener that showcase how this theme is playing out. The three stocks in this article are just a starting...
NYSE:DAL
NYSE:DALAirlines

Delta Air Lines (DAL) Could Be 41% Overvalued As Earnings Growth Draws Fresh Attention

Delta Air Lines (DAL) heads into its next earnings release with expectations for 28.07% year-over-year EPS growth and a projected 6.02% revenue increase, placing the stock firmly in focus for near-term results. See our latest analysis for Delta Air Lines. Despite a recent pullback, with a 1-day share price return of -2.15% and a 7-day share price return of -2.18%, Delta Air Lines has seen a 30-day share price return of 6.15% and a 90-day share price return of 27.21%. Its 1-year total...